Array Digital Infrastructure Inc
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Anthony Carlson
- Full Time Employees
- 60
- Sector
- Communication Services
- Industry
- Telecommunications Services
- Address
- 500 West Madison Street, Suite 810 Chicago IL United States of America 60661
- IPO Date
- May 4, 1988
- CIK
- 0000821130
- Website
- arrayinc.com
- Similar Companies
- Business
- Array Digital Infrastructure, Inc. (NYSE: AD) owns and operates shared wireless communications infrastructure, including over 4,400 cell towers across the United States, enabling 5G and other wireless technologies for wireless carriers, government agencies, municipalities, wireless internet service providers, and broadband providers. The company provides tower rental services under master lease agreements; wireless roaming services; wireless eligible telecommunications carrier services; and retains certain wireless spectrum assets, with noncontrolling investment interests in additional towers. It serves consumer, business, government, and enterprise customers through colocation opportunities that support network expansion in rural and remote areas. Founded in 1983 and headquartered in Chicago, Illinois, Array Digital Infrastructure operates as a majority-owned subsidiary of Telephone and Data Systems, Inc. (NYSE: TDS). The company focuses on the wireless telecommunications infrastructure segment of the communication services industry, with operations concentrated in the United States. In August 2025, the company changed its name from United States Cellular Corporation following the completion of a transaction with T-Mobile US, Inc., under which T-Mobile acquired its wireless operations and certain spectrum assets for $4.4 billion, while Array retained its tower portfolio and entered a new master lease agreement for T-Mobile colocations on over 2,000 additional sites. It anticipates pending spectrum transactions with AT&T, expected to close by late 2025, and with Verizon, targeted for Q3 2026, alongside ongoing colocation growth initiatives that drove 68% year-over-year cash site rental revenue increases in Q3 2025. Leadership transitioned with Douglas W. Chambers serving as interim President and CEO, overseeing operational ramp-up and strategic monetization of retained assets.
Company News
BlackRock Inc. Makes New Investment in Array Digital Infrastructure Inc. $AD
Telephone and Data Systems Announces It Is No Longer Pursuing the Acquisition of Public Shares of Array Digital Infrastructure
Telephone and Data Systems Announces It Is No Longer Pursuing the Acquisition of Public Shares of Array Digital Infrastructure
SHAREHOLDER ALERT: Kaskela Law Announces Investigation of Array Digital Infrastructure (NYSE: AD) and Encourages Current Array Shareholders to Contact the Firm
Reviewing NTT (OTCMKTS:NTTYY) & Array Digital Infrastructure (NYSE:AD)
Array Digital Infrastructure Q2 Earnings Call Highlights
AD Q2 Earnings Beat Estimates on Strong Site Rental Growth
Array Digital Infrastructure (AD) Q2 Earnings and Revenues Beat Estimates
Array reports second quarter 2026 results
Zacks Industry Outlook Array Digital, Optimum and AT&T
3 Wireless Stocks Set to Overcome Roadblocks on Industry Strength
TDS and Array to release second quarter operating results and host conference call on August 7, 2026
Dimensional Fund Advisors LP Increases Stock Position in Array Digital Infrastructure Inc. $AD
LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board of Directors
More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treat
LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference®
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis
AD Mortgage Survey Finds Growing Demand for Non-QM Lending Among Brokers